We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
(-4.8%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$117M |
| 2 |
Entegris
ENTG
|
+$107M |
| 3 |
Teleflex
TFX
|
+$26.6M |
| 4 |
Nike
NKE
|
+$25.8M |
| 5 |
S&P Global
SPGI
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.8M |
| 3 |
IAA
IAA, Inc. Common Stock
IAA
|
+$39.5M |
| 4 |
Amazon
AMZN
|
+$37.6M |
| 5 |
UnitedHealth
UNH
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.69% |
| 2 | Technology | 15.09% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Communication Services | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Royal Bank of Canada
RY
$291B
| $655K | ﹤0.01% |
7,280
| – | – |
|
452
Jacobs Solutions
J
$15.9B
| $654K | ﹤0.01% |
7,297
| – | – |
|
|
SPE
453
Special Opportunities Fund
SPE
$140M
| $642K | ﹤0.01% |
60,631
+3,455
| +6% | +$41.9K |
|
|
MRSH
454
Marsh
MRSH
$86.3B
| $635K | ﹤0.01% |
4,253
+75
| +2% | +$12K |
|
455
Sprott Physical Silver Trust
PSLV
$11.9B
| $633K | ﹤0.01% |
97,395
| – | – |
|
456
Vanguard Mid-Cap Growth ETF
VOT
$19B
| $633K | ﹤0.01% |
3,716
+65
| +2% | +$12.3K |
|
457
Shell
SHEL
$245B
| $619K | ﹤0.01% |
12,452
-4,626
| -27% | -$238K |
|
458
Phillips 66
PSX
$82.9B
| $613K | ﹤0.01% |
7,604
| – | – |
|
459
Verisk Analytics
VRSK
$26.4B
| $613K | ﹤0.01% |
3,600
| – | – |
|
460
Avanos Medical
AVNS
$1.17B
| $610K | ﹤0.01% |
28,036
+1
| +0% | +$26 |
|
|
CWBC
461
DELISTED
Community West BanCshares
CWBC
| $606K | ﹤0.01% |
43,492
| – | – |
|
462
Lumentum
LITE
$59.4B
| $603K | ﹤0.01% |
8,795
-3,050
| -26% | -$253K |
|
463
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
| $601K | ﹤0.01% |
11,099
-357
| -3% | -$21.6K |
|
464
iShares MSCI Emerging Markets ETF
EEM
$28B
| $600K | ﹤0.01% |
17,227
+14,258
| +480% | +$556K |
|
465
SB Financial Group
SBFG
$160M
| $600K | ﹤0.01% |
35,627
| – | – |
|
466
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $596K | ﹤0.01% |
18,850
-15,300
| -45% | -$513K |
|
467
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
| $596K | ﹤0.01% |
4,686
-745
| -14% | -$105K |
|
468
Rayonier
RYN
$6.49B
| $595K | ﹤0.01% |
21,902
+1,102
| +5% | +$35.6K |
|
469
Energy Transfer Partners
ET
$70.1B
| $594K | ﹤0.01% |
53,921
| – | – |
|
470
HSBC
HSBC
$355B
| $593K | ﹤0.01% |
22,760
| – | – |
|
|
DNMR
471
DELISTED
Danimer Scientific, Inc.
DNMR
| $590K | ﹤0.01% |
5,005
-625
| -11% | -$111K |
|
|
B
472
Barrick Mining
B
$62.2B
| $582K | ﹤0.01% |
37,569
+7
| +0% | +$110 |
|
473
Ametek
AME
$55.5B
| $581K | ﹤0.01% |
5,130
+300
| +6% | +$36K |
|
474
Caterpillar
CAT
$409B
| $577K | ﹤0.01% |
3,519
+4
| +0.1% | +$731 |
|
475
Eagle Bancorp Montana
EBMT
$186M
| $574K | ﹤0.01% |
30,236
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2022 Portfolio in Review
As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
- First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
- First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
- First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
- First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
- First Manhattan opened 84 new positions and closed 104 in Q3 2022.
- First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.
Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.